Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus

NCT00626717 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.

NCT NCT00626717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00626717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus
Lead sponsor
University Hospital Freiburg
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2007
Completion date
December 31, 2012
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keratoconus